Bonfiglio, V.; Platania, C.B.M.; Lazzara, F.; Conti, F.; Pizzo, C.; Reibaldi, M.; Russo, A.; Fallico, M.; Ortisi, E.; Pignatelli, F.;
et al. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy. Int. J. Mol. Sci. 2020, 21, 9558.
https://doi.org/10.3390/ijms21249558
AMA Style
Bonfiglio V, Platania CBM, Lazzara F, Conti F, Pizzo C, Reibaldi M, Russo A, Fallico M, Ortisi E, Pignatelli F,
et al. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy. International Journal of Molecular Sciences. 2020; 21(24):9558.
https://doi.org/10.3390/ijms21249558
Chicago/Turabian Style
Bonfiglio, Vincenza, Chiara Bianca Maria Platania, Francesca Lazzara, Federica Conti, Corrado Pizzo, Michele Reibaldi, Andrea Russo, Matteo Fallico, Elina Ortisi, Francesco Pignatelli,
and et al. 2020. "TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy" International Journal of Molecular Sciences 21, no. 24: 9558.
https://doi.org/10.3390/ijms21249558
APA Style
Bonfiglio, V., Platania, C. B. M., Lazzara, F., Conti, F., Pizzo, C., Reibaldi, M., Russo, A., Fallico, M., Ortisi, E., Pignatelli, F., Longo, A., Avitabile, T., Drago, F., & Bucolo, C.
(2020). TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy. International Journal of Molecular Sciences, 21(24), 9558.
https://doi.org/10.3390/ijms21249558